BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 22150304)

  • 21. Prognostic significance of P2RY8-CRLF2 and CRLF2 overexpression may vary across risk subgroups of childhood B-cell acute lymphoblastic leukemia.
    Dou H; Chen X; Huang Y; Su Y; Lu L; Yu J; Yin Y; Bao L
    Genes Chromosomes Cancer; 2017 Feb; 56(2):135-146. PubMed ID: 27637012
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined analysis of
    Cui L; Gao C; Wang CJ; Zhao XX; Li WJ; Li ZG; Zheng HY; Wang TY; Zhang RD
    Leuk Lymphoma; 2021 Feb; 62(2):410-418. PubMed ID: 33054468
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New strategies in acute lymphoblastic leukemia: translating advances in genomics into clinical practice.
    Mullighan CG
    Clin Cancer Res; 2011 Feb; 17(3):396-400. PubMed ID: 21149616
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Characteristics and Clinical Significance of CRLF2 Mutations in Adult Acute Lymphoblastic Leukemia].
    Gu Y; Wu YJ; Han Q; Zhou XL; Qiao C; Li JY; Ge Z
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Apr; 25(2):328-333. PubMed ID: 28446270
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CRLF2 expression associates with ICN1 stabilization in T-cell acute lymphoblastic leukemia.
    Maciel ALT; Poubel CP; Noronha EP; Pombo-de-Oliveira MS; Mansur MB; Emerenciano M
    Genes Chromosomes Cancer; 2019 Jun; 58(6):396-401. PubMed ID: 30578688
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rearrangement of CRLF2 in B-progenitor- and Down syndrome-associated acute lymphoblastic leukemia.
    Mullighan CG; Collins-Underwood JR; Phillips LA; Loudin MG; Liu W; Zhang J; Ma J; Coustan-Smith E; Harvey RC; Willman CL; Mikhail FM; Meyer J; Carroll AJ; Williams RT; Cheng J; Heerema NA; Basso G; Pession A; Pui CH; Raimondi SC; Hunger SP; Downing JR; Carroll WL; Rabin KR
    Nat Genet; 2009 Nov; 41(11):1243-6. PubMed ID: 19838194
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IKZF1 alterations and expression of CRLF2 predict prognosis in adult Chinese patients with B-cell precursor acute lymphoblastic leukemia.
    Fang Q; Zhao X; Li Q; Li Y; Liu K; Tang K; Wang Y; Liu B; Wang M; Xing H; Rao Q; Tian Z; Wang J; Mi Y
    Leuk Lymphoma; 2017 Jan; 58(1):127-137. PubMed ID: 27157479
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The biology of Philadelphia chromosome-like ALL.
    Roberts KG
    Best Pract Res Clin Haematol; 2017 Sep; 30(3):212-221. PubMed ID: 29050694
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of CRLF2 Expression in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia.
    Rasekh EO; Atef AM; Khalil M; Ebeid E; Madney Y; Hamdy N
    Clin Lab; 2021 Jan; 67(1):. PubMed ID: 33491417
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genome-wide CRISPR-Cas9 screen identifies rationally designed combination therapies for CRLF2-rearranged Ph-like ALL.
    Sasaki K; Yamauchi T; Semba Y; Nogami J; Imanaga H; Terasaki T; Nakao F; Akahane K; Inukai T; Verhoeyen E; Akashi K; Maeda T
    Blood; 2022 Feb; 139(5):748-760. PubMed ID: 34587248
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Degradation of Janus kinases in CRLF2-rearranged acute lymphoblastic leukemia.
    Chang Y; Min J; Jarusiewicz JA; Actis M; Yu-Chen Bradford S; Mayasundari A; Yang L; Chepyala D; Alcock LJ; Roberts KG; Nithianantham S; Maxwell D; Rowland L; Larsen R; Seth A; Goto H; Imamura T; Akahane K; Hansen BS; Pruett-Miller SM; Paietta EM; Litzow MR; Qu C; Yang JJ; Fischer M; Rankovic Z; Mullighan CG
    Blood; 2021 Dec; 138(23):2313-2326. PubMed ID: 34110416
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CRLF2 and JAK2 in B-progenitor acute lymphoblastic leukemia: a novel association in oncogenesis.
    Roll JD; Reuther GW
    Cancer Res; 2010 Oct; 70(19):7347-52. PubMed ID: 20807819
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ph-like acute lymphoblastic leukemia: a high-risk subtype in adults.
    Jain N; Roberts KG; Jabbour E; Patel K; Eterovic AK; Chen K; Zweidler-McKay P; Lu X; Fawcett G; Wang SA; Konoplev S; Harvey RC; Chen IM; Payne-Turner D; Valentine M; Thomas D; Garcia-Manero G; Ravandi F; Cortes J; Kornblau S; O'Brien S; Pierce S; Jorgensen J; Shaw KR; Willman CL; Mullighan CG; Kantarjian H; Konopleva M
    Blood; 2017 Feb; 129(5):572-581. PubMed ID: 27919910
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CRLF2 overexpression defines an immature-like subgroup which is rescued through restoration of the PRC2 function in T-cell precursor acute lymphoblastic leukemia.
    Maciel ALT; Wolch K; Emerenciano M; Mansur MB
    Genes Chromosomes Cancer; 2022 Jul; 61(7):437-442. PubMed ID: 35253299
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting signaling pathways in acute lymphoblastic leukemia: new insights.
    Harrison CJ
    Hematology Am Soc Hematol Educ Program; 2013; 2013():118-25. PubMed ID: 24319172
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The prognostic significance of
    Wang J; Sun K; Chen WM; Wang X; Li LD; Hao Y; Xu N; Jiang H; Xu LP; Wang Y; Zhang XH; Huang XJ; Jiang Q; Qin YZ
    Leuk Lymphoma; 2023 Mar; 64(3):698-706. PubMed ID: 36642937
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High occurrence of CRLF2 abnormalities in Mexican children with B-cell acute lymphoblastic leukemia.
    Juárez-Velázquez MDR; Moreno-Lorenzana DL; Martínez Anaya DA; Hernández Monterde EA; Aguilar-Hernández MM; Reyes-León A; Chávez-González MA; López Santiago N; Zapata Tarrés M; Juárez Villegas L; Rivera Sánchez N; Soto Lerma O; Vega-Vega L; Rivera Luna R; Pérez-Vera P
    Cytokine; 2022 Jul; 155():155896. PubMed ID: 35537330
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CRLF2 overexpression identifies an unfavourable subgroup of adult B-cell precursor acute lymphoblastic leukemia lacking recurrent genetic abnormalities.
    Chiaretti S; Brugnoletti F; Messina M; Paoloni F; Fedullo AL; Piciocchi A; Elia L; Vitale A; Mauro E; Ferrara F; De Fabritiis P; Luppi M; Ronco F; De Propris MS; Raponi S; Kronnie GT; Vignetti M; Guarini A; Foà R
    Leuk Res; 2016 Feb; 41():36-42. PubMed ID: 26754556
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic significance of cytokine receptor-like factor 2 alterations in acute lymphoblastic leukemia: a meta-analysis.
    Jia M; Wang ZJ; Zhao HZ; Shen HP; Cheng YP; Luo ZB; Tang YM
    World J Pediatr; 2015 May; 11(2):126-33. PubMed ID: 25920591
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterisation of the genomic landscape of CRLF2-rearranged acute lymphoblastic leukemia.
    Russell LJ; Jones L; Enshaei A; Tonin S; Ryan SL; Eswaran J; Nakjang S; Papaemmanuil E; Tubio JM; Fielding AK; Vora A; Campbell PJ; Moorman AV; Harrison CJ
    Genes Chromosomes Cancer; 2017 May; 56(5):363-372. PubMed ID: 28033648
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.